pd 98059 has been researched along with Sarcoma, Ewing in 3 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zenali, MJ | 1 |
| Zhang, PL | 1 |
| Bendel, AE | 1 |
| Brown, RE | 1 |
| Jung, HS | 1 |
| Kim, HS | 1 |
| Lee, MJ | 1 |
| Shin, HY | 1 |
| Ahn, HS | 1 |
| Ryu, KH | 1 |
| Seoh, JY | 1 |
| Kim, CJ | 1 |
| Jang, JJ | 1 |
| Silvany, RE | 1 |
| Eliazer, S | 1 |
| Wolff, NC | 1 |
| Ilaria, RL | 1 |
3 other studies available for pd 98059 and Sarcoma, Ewing
| Article | Year |
|---|---|
Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors.
Topics: 12E7 Antigen; Antigens, CD; Cell Adhesion Molecules; Cell Line, Tumor; Cell Nucleus; Extracellular S | 2009 |
Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tum | 2006 |
Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Topics: 3T3 Cells; Animals; Binding Sites; Bone Neoplasms; Butadienes; Cell Transformation, Neoplastic; Colo | 2000 |